Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib Resistance After Failure of Chemotherapy

Dramatic Response to Teriprilumab and Anlotinib Combination Therapy in a patient with EGFR-Mutant Lung Adenocarcinoma Who Experienced Small-Cell Transformation−Mediated Erlotinib Resistance After Failure of Chemotherapy

Bibliographic Details
Main Authors: Yuling Zhou, MS, Liang Zeng, MS, Nong Yang, MS, Yongchang Zhang, MD
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:JTO Clinical and Research Reports
Subjects:
Anlotinib
Teriprilumab
EGFR
Erlotinib
Small cell lung cancer transformation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320300102
Description
ISSN:2666-3643

Similar Items